Proposed 20th wave technology appraisals
| Topic: | Psoriasis (children) - etanercept |
| Suggested remit: | To appraise the clinical and cost effectiveness of etanercept within its licensed indication for the treatment of moderate to severe chronic plaque psoriasis in children and adolescents |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators: | 1 December 2008 - 2 January 2009 |
| Scoping workshop | 23 January 2009 (afternoon meeting) in London |
| Enquiries to: | jenniffer.alty@nice.org.uk |
| Consultation document(s): |
| Topic: | Osteoporosis (post-menopausal) primary prevention - denosumab |
| Suggested remit: | To appraise the clinical and cost effectiveness of denosumab within its licensed indication for the primary prevention of osteoporotic fractures in postmenopausal women. |
| Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators: | 9 December 2008 - 12 January 2009 |
| Scoping workshop | 28 January 2009 (afternoon meeting) in London |
| Enquiries to: | jenniffer.alty@nice.org.uk |
| Consultation document(s): |